Hamilton, JR, Sato, N. Jaundice associated with severe bacterial infection in young infants. Pediatrics 1963;63:121–32.Google Scholar

Shamir, R, Maayan-Metzger, A, Bujanover, Y, et al. Liver enzyme abnormalities in Gram-negative bacteremia of premature infants. Pediatr Infect Dis J 2000;19:495–8.Google Scholar

Lanza, JS, Rosato, EL. Regulatory factors in the development of fatty infiltration of the liver during Gram-negative sepsis. Metabolism 1994;43:691–6.Google Scholar

Chusid, MJ. Pyogenic hepatic abscess in infancy and childhood. Pediatrics 1978;62:554–9.CrossRefGoogle ScholarPubMed

Mishra, K, Basu, S, Roychoudhury, S, Kumar, P. Liver abscess in children: an overview. World J Pediatr 2010;6:210–16.CrossRefGoogle ScholarPubMed

Haider, SJ, Tarulli, M, McNulty, NJ, Hoffer, EK. Liver abscesses: factors that influence outcome of percutaneous drainage. AJR 2017;209;205–13.Google Scholar

Pineiro, CV, Andres, JM. Morbidity and mortality in children with pyogenic liver abscess. Am J Dis Child 1989;143:1424–7.Google Scholar

Lederman, ER, Crum, NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 2005;100:322–31.Google Scholar

Pelton, SI, Kim, JY, Kradin, RL. Case records of the Massachusetts General Hospital. Case 27–2006. A 17-year-old boy with fever and lesions in the liver and spleen. N Engl J Med 2006;355:941–8.Google Scholar

Rayes, AA, Teixeira, D, Serufo, JC, et al. Human toxocariasis and pyogenic liver abscess: a possible association. Am J Gastroenterol 2001;96:563–6.Google Scholar

Muorah, M, Hinds, R, Verma, A, et al. Liver abscesses in children: a single center experience in the developed world. J Pediatr Gastroenterol Nutr 2006;42:201–6.Google Scholar

Bari, S, Sheikh, KA, Malik, AA, Wani, RA, Naqash, SH. Percutaneous aspiration versus open drainage of liver abscess in children. Pediatr Surg Int 2007;23:69–74.CrossRefGoogle ScholarPubMed

Ecoffey, C, Rothman, E, Bernard, O, et al. Bacterial cholangitis after surgery for biliary atresia. J Pediatr 1987;111(6 Pt 1): 824–9.CrossRefGoogle ScholarPubMed

Bornman, PC, van Beljon, JI, Krige, JE. Management of cholangitis. J Hepatobiliary Pancreat Surg 2003;10:406–14.Google Scholar

Desmet, DM. (1979). Cholestasis: extrahepatic obstruction and secondary biliary cirrhosis. In Macsween, RNM, Anthony, PP, Scheuer, PJ, (Eds.), Pathology of the Liver (pp. 272–305). Edinburgh: Churchill Livingstone.Google Scholar

Gerecht, WB, Henry, NK, Hoffman, WW, et al. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med 1989;149:1279–84.Google Scholar

Lee, JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroent Hepatol 2009;6:533–41.Google Scholar

Cheng, CL, Fogel, EL, Sherman, S, et al. Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J Pediatr Gastroenterol Nutr 2005;41:445–53.CrossRefGoogle ScholarPubMed

Fitz-Hugh, T. Acute gonococcic peritonitis of the right upper quadrant in women. JAMA 1934;102:2094–6.Google Scholar

Curtis, AH. A cause of adhesions in the right upper quadrant. JAMA 1930;94:1221–2.Google Scholar

Holmes, KK, Counts, GW, Beaty, HN. Disseminated gonococcal infection. Ann Intern Med 1971;74:979–93.CrossRefGoogle ScholarPubMed

Massei, F, Gori, L, Macchia, P, Maggiore, G. The expanded spectrum of bartonellosis in children. Infect Dis Clin North Am 2005;19:691–711.Google Scholar

Rocco, VK, Roman, RJ, Eigenbrodt, EH. Cat scratch disease. Report of a case with hepatic lesions and a brief review of the literature. Gastroenterology 1985;89:1400–6.Google Scholar

Byington CL for the AAP Committee on Infectious Diseases (2018). Red Book, 31st edn. Elk Grove Village, IL: American Academy of Pediatrics.Google Scholar

Ramachandran, S, Godfrey, JJ, Perera, MV. Typhoid hepatitis. JAMA 1974;230:236–40.Google Scholar

Gonzalez-Quintela, A, Campos, J, Alende, R, et al. Abnormalities in liver enzyme levels during Salmonella enteritidis enterocolitis. Rev Esp Enferm Dig 2004;96:559–62.Google Scholar

Mert, A, Tabak, F, Ozaras, R, et al. Typhoid fever as a rare cause of hepatic, splenic, and bone marrow granulomas. Intern Med 2004;43:436–9.Google Scholar

Bolton, JP, Perihepatitis, Darougar S.. Br Med Bull 1983;39:159–62.CrossRefGoogle Scholar

Lulu, AR, Araj, GF, Khateeb, MI, et al. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988;66(249):39–54.Google Scholar

Al Otaibi, FE. Acute acalculus cholecystitis and hepatitis caused by Brucella melitensis. J Infect Dev Ctries 2010;4:464–7.Google Scholar

Cervantes, F, Bruguera, M, Carbonell, J, Force, L, Webb, S. Liver disease in brucellosis. A clinical and pathological study of 40 cases. Postgrad Med J 1982;58(680):346–50.Google Scholar

Evans, ME, Gregory, DW, Schaffner, W, McGee, ZA. Tularemia: a 30-year experience with 88 cases. Medicine 1985;64:251–69.CrossRefGoogle ScholarPubMed

Crosbie, J, Varma, J, Mansfield, J. Yersinia enterocolitica infection in a patient with hemachromatosis masquerading as proximal colon cancer with liver metastases: report of a case. Dis Colon Rectum 2005;48:390–2.Google Scholar

Ishak, KG, Rogers, WA. Cryptogenic acute cholangitis-association with toxic shock syndrome. Am J Clin Pathol 1981;76:619–26.Google Scholar

Fishbein, WN. Jaundice as an early manifestation of scarlet fever. Report of three cases in adults and review of the literature. Ann Intern Med 1962;57:60–72.Google Scholar

Albrecht, H. (2003). Bacterial and miscellaneous infections of the liver. In Zakim, D, Boyer, TD, (Eds.), Hepatology (pp. 1109–24). Philadelphia, PA: Saunders.Google Scholar

Zimmerman, HJ, Thomas, LJ. The liver in pneumococcal pneumonia. Observations in 94 cases on liver function and jaundice in pneumonia. J Lab Clin Med 1950;35:556–67.Google Scholar

Korn, RJ, Kellow, WF, Heller, P, et al. Hepatic involvement in extrapulmonary tuberculosis. Am J Med 1959;27:60–71.Google Scholar

Sharma, S. (2003). Granulomatous diseases of the liver. In Zakim, D, Boyer, TD, (Eds.), Hepatology (pp. 1317–40). Philadelphia, PA: Saunders.Google Scholar

Alvarez, SZ, Carpio, R. Hepatobiliary tuberculosis. Dig Dis Sci 1983;28:193–200.CrossRefGoogle ScholarPubMed

Vijayasekaran, D. Treatment of childhood tuberculosis. Indian J Pediatr 2011;78:443–8.Google Scholar

Patel, S, DeSantis, ER. Treatment of congenital tuberculosis. Am J Health Syst Pharm 2008;65:2027–31.Google Scholar

Wilkins, MJ, Lindley, R, Dourakis, SP, Goldin, RD. Surgical pathology of the liver in HIV infection. Histopathology 1991;18:459–64.CrossRefGoogle ScholarPubMed

Mofenson, LM, Brady, MT, Danner, SP, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009;58:1–166.Google Scholar

Jonas, RB, Brasitus, TA, Chowdhury, L. Actinomycotic liver abscess. Case report and literature review. Dig Dis Sci 1987;32:1435–7.Google Scholar

Thomas, LD, Hongo, I, Bloch, KC, Tang, YW, Dummer, S. Human ehrlichiosis in transplant recipients. Am J Transplant 2007;7:1641–7.Google Scholar

Sehdev, AE, Dumler, JS. Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. Am J Clin Pathol 2003;119:859–65.Google Scholar

Listernick, R. Liver failure in a 2-day-old infant. Pediatr Ann 2004;33:10–14.Google Scholar

Wright, DJ, Berry, CL. Liver involvement in congenital syphilis. Br J Vener Dis 1974;50:241.Google Scholar

Nadelman, RB, Nowakowski, J, Forseter, G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996;100:502–8.CrossRefGoogle ScholarPubMed

Schoen, RT. Relapsing or reinfectious lyme hepatitis. Hepatology 1989;9:335–6.Google Scholar

Brown, V, Larouze, B, Desve, G, et al. Clinical presentation of louse-borne relapsing fever among Ethiopian refugees in northern Somalia. Ann Trop Med Parasitol 1988;82:499–502.Google Scholar

Wong, ML, Kaplan, S, Dunkle, LM, Stechenberg, BW, Feigin, RD. Leptospirosis: a childhood disease. J Pediatr 1977;90:532–7.Google Scholar

Feigin, RD, Anderson, DC. (2004). Leptospirosis. In Feigin, RD, Cherry, JD, Demmler, GJ, Kaplan, S, (Eds.), Textbook of Pediatric Infectious Diseases (pp. 1708–22). Philadelphia, PA: Saunders.Google Scholar

Adams, JS, Walker, DH. The liver in Rocky Mountain spotted fever. Am J Clin Pathol 1981;75:156–61.Google Scholar

Parker, NR, Barralet, JH, Bell, AM. Q fever. Lancet 2006;367:679–88.Google Scholar

Domingo, P, Orobitg, J, Colomina, J, Alvarez, E, Cadafalch, J. Liver involvement in acute Q fever. Chest 1988;94:895–6.Google Scholar

Geha, R, Peters, M, Gill, RM, Dhaliwal, G. Histology rings true. N Engl J Med 2017;376(9):869–74.Google Scholar

Hotez, PJ, Strickland, AD. (2004). Amebiasis. In Feigin, RD, Cherry, JD, Demmler, GJ, Kaplan, S (Eds.), Textbook of Pediatric Infectious Diseases (pp. 2660–9). Philadelphia, PA: Saunders.Google Scholar

Rossignol, JF, Kabil, SM, El Gohary, Y, Younis, AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg 2007;101:1025–31.Google Scholar

Chavez-Tapia, NC, Hernandez-Calleros, J, Tellez-Avila, FI, Torre, A, Uribe, M. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev 2009;1:CD004886. doi: 10.1002/14651858.CD004886.pub2Google Scholar

Agarwal, N, Kumar, S. Budd–Chiari syndrome owing to liver hydatid disease: case report and review of the literature. Ann Trop Paediatr 2009;29:301–4.Google Scholar

Nunnari, G. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol 2012;18:1448–58.Google Scholar

Kahriman, G, Ozcan, N, Dogan, S, Karaborklu, O. Percutaneous treatment of liver hydatid cysts in 190 patients: a retrospective study. Acta Radiologica 2017;58(6):676–84.CrossRefGoogle ScholarPubMed

Sciume, C, Geraci, G, Pisello, F, et al. Treatment of complications of hepatic hydatid disease by ERCP: our experience. Ann Ital Chir 2004;75:531–5.Google Scholar

Baraket, O, Feki, MN, Chaari, M, et al. Hydatid cyst open in biliary tract: therapeutic approaches. Report of 22 cases. J Visc Surg 2011;148:e211–e216.Google Scholar

Krige, J, Shaw, J. Cholangitis and pancreatitis caused by biliary ascariasis. Clin Gastroenterol Hepatol 2009;7:A30.CrossRefGoogle ScholarPubMed

Louw, JH. Abdominal complications of ascariasis. Surg Rounds 1981;4:54–65.Google Scholar

Bektas, M, Dokmeci, A, Cinar, K, et al. Endoscopic management of biliary parasitic diseases. Dig Dis Sci 2010;55:1472–8.Google Scholar

Edington, GM. (1979). Other viral and infectious diseases. In Macsween, RNM, Anthony, PP, Scheuer, PJ (Eds.), Pathology of the Liver (pp. 192–220). Edinburgh: Churchill Livingstone.Google Scholar

Bica, I, Hamer, DH, Stadecker, MJ. Hepatic schistosomiasis. Infect Dis Clin North Am 2000;14:583–604.Google Scholar

Symmers, W. Note on a new form of liver cirrhosis due to the presence of ova of Bilharzia haematobium. J Pathol Bacteriol 1903;9:237–9.Google Scholar

Namwanje, H, Kabatereine, N, Olsen, A. A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda. Trans R Soc Trop Med Hyg 2011;105:181–8.Google Scholar

Qian, M, Utzinger, J, Keiser, J, Zjou, X. Clonorchiasis. Lancet 2016;387:800–10.CrossRefGoogle Scholar

Karahocagil, MK, Akdeniz, H, Sunnetcioglu, M, et al. A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature. Acta Trop 2011;118:177–83.Google Scholar

Moreno, A, Marazuela, M, Yebra, M, et al. Hepatic fibrin-ring granulomas in visceral leishmaniasis. Gastroenterology 1988;95:1123–6.Google Scholar

Rajagopala, S, Dutta, U, Chandra, KS, et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis: case report and systematic review. J Infect 2008;56:381–8.Google Scholar

Tangpukdee, N, Thanachartwet, V, Krudsood, S, et al. Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment. Korean J Parasitol 2006;44:295–302.Google Scholar

Kaely, N, Ahmad, S, Shirazi, N, Bhatia, R, Bhat, NK, Srivastava, S, Dhar, M, Kumar, M. Malarial hepatopathy: a 6-year retrospective observational study from Uttarakhand, North India. Tran R Soc Trop Med Hyg 2017;111(5):220–5.CrossRefGoogle Scholar

Raphemot, R, Posfai, D, Derbyshire, ER. Current therapies and future possibilities for drug development against liver-stage malaria. J Clin Invest 2016;126(6):2013–20.Google Scholar

Epstein, JE, Tewari, K, Lyke, KE, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity. Science 2011;334(6055):475–80.CrossRefGoogle ScholarPubMed

Thaler, M, Pastakia, B, Shawker, TH, O’Leary, T, Pizzo, PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988;108:88–100.Google Scholar

Aikawa, N, Kusachi, S, Oda, S, Takesue, Y, Tanaka, H. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm. J Infect Chemother 2009;15:219–27.Google Scholar

Meyer, MH, Letscher-Bru, V, Waller, J, et al. Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin Infect Dis 2002;35:e22–e25.Google Scholar

Kantipong, P, Panich, V, Pongsurachet, V, Watt, G. Hepatic penicilliosis in patients without skin lesions. Clin Infect Dis 1998;26:1215–17.Google Scholar

Keckich, DW, Blair, JE, Vikram, HR. Coccidioides fungemia in six patients, with a review of the literature. Mycopathologia 2010;170:107–15.CrossRefGoogle ScholarPubMed

Smith, G, Hoover, S, Sobonya, R, Klotz, SA. Abdominal and pelvic coccidioidomycosis. Am J Med Sci 2011;341:308–11.Google Scholar

Troillet, N, Llor, J, Kuchler, H, Deleze, G, Praz, G. Disseminated histoplasmosis in an adopted infant from El Salvador. Eur J Pediatr 1996;155:474–6.Google Scholar

Hasan, RA, Abuhammour, W. Invasive aspergillosis in children with hematologic malignancies. Paediatr Drugs 2006;8:15–24.Google Scholar

Katragkou, A, Fisher, BT, Groll, AH, Roilides, E, Walsh, TJ. Diagnostic imaging and invasive fungal diseases in children. JPIDS 2017;6:S22–S31.Google Scholar

Boon, AP, O’Brien, D, Adams, DH. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol 1991;44:452–4.Google Scholar

Brienza, N, et al. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 2006;32(2):267–74.Google Scholar

Jakob, SM, et al. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol 2001;280(5):G819–27.Google Scholar

Brienza, N, et al. Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med 1995;152(2):504–10.Google Scholar

Parker, GA, Picut, CA. Immune functioning in nonlymphoid organs: the liver. Toxicol Pathol 2011. https://doi.org/10.1177/0192623311428475Google Scholar

Sander, LE, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010;207(7):1453–64.CrossRefGoogle ScholarPubMed

Sakamori, R, et al. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 2007;46(5):1564–73.Google Scholar

Geier, A, Fickert, P, Trauner, M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006;3(10):574–85.Google Scholar

McDonald, B, Kubes, P. Neutrophils and intravascular immunity in the liver during infection and sterile inflammation. Toxicol Pathol 2011. https://doi.org/10.1177/0192623311427570Google Scholar

Lin, CC, et al. Subacute nonsuppurative cholangitis (cholangitis lenta) in pediatric liver transplant patients. J Pediatr Gastroenterol Nutr 2007;45(2):228–33.Google Scholar

Torous, VF, et al. Cholangitis lenta: a clinicopathologic study of 28 cases. Am J Surg Pathol 2017;41(12):1607–17.Google Scholar

Lefkowitch, JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and “cholangitis lenta.” Hum Pathol 1982;13(1):19–24.Google Scholar

Lautt, WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res 2007;37(11):891–903.Google Scholar

Eipel, C, Abshagen, K, Vollmar, B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010;16(48):6046–57.CrossRefGoogle ScholarPubMed

Vollmar, B, Menger, MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009;89(4):1269–339.Google Scholar

Gracia-Sancho, J, Marrone, G, Fernandez-Iglesias, A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol 2019;16(4):221–34.Google Scholar

Wu, Y, et al. Laser speckle contrast imaging for measurement of hepatic microcirculation during the sepsis: a novel tool for early detection of microcirculation dysfunction. Microvasc Res 2015;97:137–46.Google Scholar

Fan, J, et al. Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice. World J Gastroenterol 2019;25(11):1355–65.Google Scholar

Ebert, EC. Hypoxic liver injury. Mayo Clin Proc 2006;81(9):1232–6.Google Scholar

Jäger, B, et al. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology 2012;56(6):2297–304.Google Scholar

Peltenburg, HG, et al. Estimation of the fractional catabolic rate constants for the elimination of cytosolic liver enzymes from plasma. Hepatology 1989;10(5):833–9.Google Scholar

Tapper, EB, Sengupta, N, Bonder, A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med 2015;128(12):1314–21.Google Scholar

Van den Broecke, A, et al. Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis. Ann Intensive Care 2018;8(1):15.Google Scholar

Samavati, L, et al. Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem 2008;283(30):21134–44.Google Scholar

Horvatits, T, et al. Circulating bile acids predict outcome in critically ill patients. Ann Intensive Care 2017;7(1):48.Google Scholar

Gudnason, HO, Björnsson, ES. Secondary sclerosing cholangitis in critically ill patients: current perspectives. Clin Exp Gastroenterol 2017;10:105–11.Google Scholar

Leonhardt, S, et al. Secondary sclerosing cholangitis in critically ill patients: clinical presentation, cholangiographic features, natural history, and outcome: a series of 16 cases. Medicine 2015;94(49):e2188.CrossRefGoogle Scholar

Arcidi, JM Jr., Moore, GW, Hutchins, GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 1981;104(2):159–66.Google Scholar

Matsuda, H, et al. Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. Analysis of the contributing factors and its relation to the early prognosis. J Thorac Cardiovasc Surg 1988;96(2):219–26.Google Scholar

Camposilvan, S, et al. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008;86(1):177–82.Google Scholar

Wu, FM, et al. Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011;6(3):190–201.Google Scholar

Goldberg, DJ, et al. Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 2017;6(5):pii:e004809. doi:10.1161/JAHA.116.004809Google Scholar

Pike, NA, et al. Clinical profile of the adolescent/adult Fontan survivor. Congenit Heart Dis 2011;6(1):9–17.Google Scholar

Yang, HK, et al. CT and MR imaging findings of the livers in adults with Fontan palliation: an observational study. Abdom Radiol 2020;45:188–202.Google Scholar

Rutledge, BP, et al. Transplant-amenable hepatocellular carcinoma in a Fontan patient. Case Rep Gastroenterol 2019;13(2):275–9.Google Scholar

Alsaied, T, et al. Relation of magnetic resonance elastography to Fontan failure and portal hypertension. Am J Cardiol 2019;124(9):1454–9.Google Scholar

Chen, H, et al. Budd–Chiari syndrome caused by multiple membranous obstruction of the inferior vena cava in a young man. Ann Vasc Surg 2011;25(8):1139 e5–7.Google Scholar

Shetty, S, Ghosh, K. Thrombophilic dimension of Budd-Chiari syndrome and portal venous thrombosis–a concise review. Thromb Res 2011;127(6):505–12.Google Scholar

Hernández-Gea, V, et al. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol 2019;71(1):175–99.Google Scholar

Qi, X, et al. Review article: the aetiology of primary Budd-Chiari syndrome – differences between the West and China. Aliment Pharmacol Ther 2016;44(11–12):1152–1167.Google Scholar

Hoekstra, J, et al. Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome. Blood 2010;115(2):388–95.Google Scholar

Zhang, P, et al. Association between JAK2 rs4495487 polymorphism and risk of Budd-Chiari syndrome in China. Gastroenterol Res Pract 2015;2015:807–65.Google Scholar

Shukla, A, et al. Budd-Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int 2018;12(6):560–6.Google Scholar

Coskun, ME, et al. Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome. BMJ Case Rep 2017;2017:pii:bcr-2017-220377. doi: 10.1136/bcr-2017-220377Google Scholar

Karakose, S, et al. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis. Turk J Gastroenterol 2015;26(1):42–8.Google Scholar

Singh, V, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 2000;15(5):550–4.Google Scholar

Nobre, S, et al. Primary Budd-Chiari syndrome in children: King’s College Hospital Experience. J Pediatr Gastroenterol Nutr 2017;65(1):93–6.CrossRefGoogle ScholarPubMed

Boozari, B, et al. Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications. J Hepatol 2008;49(4):572–80.Google Scholar

Faraoun, SA, et al. Budd-Chiari syndrome: an update on imaging features. Clin Imaging 2016;40(4):637–46.Google Scholar

Wang, L, et al. Diagnosis of Budd-Chiari syndrome: three-dimensional dynamic contrast enhanced magnetic resonance angiography. Abdom Imaging 2011;36(4):399–406.Google Scholar

Nagral, A, et al. Budd-Chiari syndrome in children: experience with therapeutic radiological intervention. J Pediatr Gastroenterol Nutr 2010;50(1):74–8.Google Scholar

Wang, Q, et al. Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial. Lancet Gastroenterol Hepatol 2019;4(9):686–97.Google Scholar

Sharma, VK, et al. Long-term clinical outcome of Budd-Chiari syndrome in children after radiological intervention. Eur J Gastroenterol Hepatol 2016;28(5):567–75.Google Scholar

Koskinas, J, et al. Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors. Scand J Gastroenterol 2007;42(4):499–507.CrossRefGoogle ScholarPubMed

Allali, S, et al. Hepatobiliary complications in children with sickle cell disease: a retrospective review of medical records from 616 patients. J Clin Med 2019;8(9):pii:E1481. doi: 10.3390/jcm8091481Google Scholar

Ebert, EC, Nagar, M, Hagspiel, KD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol 2010;8(6):483–9; quiz e70.Google Scholar

Herrera, JL. Liver in systemic diseases. Clin Liver Dis 2019;23(2):i.Google Scholar

Ahn, H, Li, CS, Wang, W. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 2005;45(2):184–90.Google Scholar

Mekeel, KL, et al. Liver transplantation in children with sickle-cell disease. Liver Transpl 2007;13(4):505–8.Google Scholar

Emre, S, et al. Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation 2000;69(4):675–6.Google Scholar

Blinder, MA, et al. Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature. Hematol Rep 2013;5(1):1–4.Google Scholar

Revel-Vilk, S, et al. The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity. Haemophilia 2011;17(4):689–94.Google Scholar

Alvarnas, JC, et al. Acute lymphoblastic leukemia. J Natl Compr Canc Netw 2015;13(10):1240–79.Google Scholar

Denton, CC, et al. Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. Pediatr Blood Cancer 2018;65(3). doi: 10.1002/pbc.26891Google Scholar

Hashmi, SK, et al. Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2019;2019:e28063.Google Scholar

Farrow, AC, et al. Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 1997;15(4):1560–6.Google Scholar

Kamal, N, et al. Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis. Hepatol Int 2019;13(5):641–8.Google Scholar

Aldoss, I, et al. Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia. Eur J Haematol 2016;96(4):375–80.Google Scholar

Schulte, RR, et al. Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma 2018;59(10):2360–8.Google Scholar

Blackman, A, et al. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: a case report and review of the literature. J Oncol Pharm Pract 2018;24(5):393–7.Google Scholar

Athale, U, et al. Management of chronic myeloid leukemia in children and adolescents: recommendations from the Children’s Oncology Group CML Working Group. Pediatr Blood Cancer 2019;66(9):e27827.Google Scholar

Pass, AK, et al. Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. J Pediatr Hematol Oncol 2008;30(12):976–80.Google Scholar

Ballonoff, A, et al. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol 2008;47(5):962–70.Google Scholar

Ghosh, I, Bakhshi, S. Jaundice as a presenting manifestation of pediatric non-Hodgkin lymphoma: etiology, management, and outcome. J Pediatr Hematol Oncol 2010;32(4):e131–5.Google Scholar

McDonald, GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 2010;51(4):1450–60.Google Scholar

Mahadeo, KM, et al. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol 2019. doi: https://doi.org/10.1016/S2352-3026(19)30201-7Google Scholar

Corbacioglu, S, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant 2018;53(2):138–45.Google Scholar

McCarville, MB, et al. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol 2001;31(2):102–5.Google Scholar

Shulman, HM, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995;59(7):1015–22.Google Scholar

Cheuk, DK, et al. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. Cochrane Database Syst Rev 2015;5:CD009311.Google Scholar

Tay, J, et al. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007;13(2):206–17.Google Scholar

Corbacioglu, S, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 2012;379(9823):1301–9. doi: 10.1016/S0140-6736(11)61938-7Google Scholar

Bajwa, RPS, et al. Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment. Biol Blood Marrow Transplant 2017;23(11):1817–25.Google Scholar

Mahadeo, KM, et al. Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues. Biol Blood Marrow Transplant 2017;23(12):2023–33.Google Scholar

Coppell, JA, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010;16(2):157–68.Google Scholar

Pidala, J. Graft-vs-host disease following allogeneic hematopoietic cell transplantation. Cancer Control 2011;18(4):268–76.Google Scholar

Matsukuma, KE, et al. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol 2016;7(Suppl. 1):S21–31.Google Scholar

Ruggiu, M, et al. Utility and safety of liver biopsy in patients with undetermined liver blood test anomalies after allogeneic hematopoietic stem cell transplantation: a monocentric retrospective cohort study. Biol Blood Marrow Transplant 2018;24(12):2523–31.Google Scholar

Oshrine, B, Lehmann, LE, Duncan, CN. Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2011;33(3):e92–7.Google Scholar

Salomao, M, et al. Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update. Am J Clin Pathol 2016;145(5):591–603.Google Scholar

Shulman, HM, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006;12(1):31–47.CrossRefGoogle ScholarPubMed

Jamil, MO, Mineishi, S. State-of-the-art acute and chronic GVHD treatment. Int J Hematol 2015;101(5):452–66.Google Scholar

Cutler, CS, Koreth, J, Ritz, J. Mechanistic approaches for the prevention and treatment of chronic GVHD. Blood 2017;129(1):22–9.Google Scholar

Barshes, NR, et al. Liver transplantation for severe hepatic graft-versus-host disease. An analysis of aggregate survival data. Liver Transplantation 2005;11(5):525–31.Google Scholar

Zeidan, AM, et al. Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant. Leuk Lymphoma 2013;54(12):2756–9.Google Scholar

Tomita, Y, et al. High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. Bone Marrow Transplant 2011;46(3):416–25.Google Scholar

Behrens, EM, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol 2008;35(2):343–8.Google Scholar

Lee, JJY, Schneider, R. Systemic juvenile idiopathic arthritis. Pediatr Clin North Am 2018;65(4):691–709.Google Scholar

Takahashi, A, et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res 2010;40(11):1092–7.Google Scholar

Hashkes, PJ, et al. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Peds 1999;134:47–52.Google Scholar

Wood, PR, Caplan, L. Drug-induced gastrointestinal and hepatic disease associated with biologic and nonbiologic disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 2018;44(1):29–43.Google Scholar

Kaplowitz, N, DeLeve, LD. (2007). Drug-Induced Liver Disease, 2nd edn., (pp. xv, 8081). New York: Informa Healthcare.Google Scholar

Shimizu, M, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology 2010;49(9):1645–53.Google Scholar

Minoia, F, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014;66(11):3160–9.Google Scholar

Ebert, EC, Hagspiel, KD. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig Dis Sci 2011;56(2):295–302.Google Scholar

Harry, O, Yasin, S, Brunner, H. Childhood-onset systemic lupus erythematosus: a review and update. J Pediatr 2018;196:22–30.e2.Google Scholar

Gebreselassie, A, Aduli, F, Howell, CD. Rheumatologic diseases and the liver. Clin Liver Dis 2019;23(2):247–61.Google Scholar

Ohira, H, et al. High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 2004;28(3):137–9.Google Scholar

Vanoni, F, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clin Rev Allergy Immunol 2017;53(3):469–76.Google Scholar

Lee, LA, Sokol, RJ, Buyon, JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109(1):E11.Google Scholar

Eladawy, M, et al. Abnormal liver panel in acute kawasaki disease. Pediatr Infect Dis J 2011;30(2):141–4.Google Scholar

Wang, Y, et al. Unique molecular patterns uncovered in Kawasaki disease patients with elevated serum gamma glutamyl transferase levels: implications for intravenous immunoglobulin responsiveness. PLoS One 2016;11(12):e0167434.Google Scholar

Kim, BY, et al. Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in Korean children. Korean Circ J 2016;46(4):542–9.Google Scholar

Grammatikopoulos, T, et al. Reduced hepatocellular expression of canalicular transport proteins in infants with neonatal cholestasis and congenital hypopituitarism. J Pediatr 2018;200:181–7.Google Scholar

Malik, R, Hodgson, H. The relationship between the thyroid gland and the liver. QJM 2002;95(9):559–69.Google Scholar

Eshraghian, A, Hamidian Jahromi, A. Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review. World J Gastroenterol 2014;20(25):8102–9.Google Scholar

Elder, CJ, Natarajan, A. Mauriac syndrome–a modern reality. J Pediatr Endocrinol Metab 2010;23(3):311–13.Google Scholar

Sumida, Y, Yoneda, M. Glycogen hepatopathy: an under-recognized hepatic complication of uncontrolled type 1 diabetes mellitus. Intern Med 2018;57(8):1063–4.Google Scholar

Rubio-Tapia, A, Murray, JA. The liver and celiac disease. Clin Liver Dis 2019;23(2):167–76.Google Scholar

Mounajjed, T, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol 2011;136(1):128–37.Google Scholar

Finn, PF, Dice, JF. Proteolytic and lipolytic responses to starvation. Nutrition 2006;22(7–8):830–44.Google Scholar

Grover, Z, Ee, LC. Protein energy malnutrition. Pediatr Clin North Am 2009;56(5):1055–68.Google Scholar

Fong, HF, et al. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa. J Pediatr 2008;153(2):247–53.Google Scholar

Rautou, PE, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008;135(3):840–8, 848.e1–3.CrossRefGoogle ScholarPubMed

Nadelson, AC, et al. Expanding the differential diagnosis for transaminitis in patients with anorexia nervosa. J Gen Intern Med 2017;32(4):486–9.Google Scholar

De Caprio, C, et al. Severe acute liver damage in anorexia nervosa: two case reports. Nutrition 2006;22(5):572–5.Google Scholar

Rosen, E, et al. Hepatic complications of anorexia nervosa. Dig Dis Sci 2017;62(11):2977–81.Google Scholar

Navarro, VJ, et al. Liver injury from herbal and dietary supplements. Hepatology 2017;65(1):363–73.Google Scholar

García-Cortés, M, et al. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics.Int J Mol Sci 2016;17(4):537.Google Scholar

Dulai, PS, Rothstein, RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol 2012;46(5):367–74. doi: 10.1097/MCG.0b013e318247106bGoogle Scholar

Kumar, M, Herrera, JL. Sarcoidosis and the liver. Clin Liver Dis 2019;23(2):331–43.Google Scholar

Cremers, J, et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol 2012;24(1):17–24.Google Scholar

Vuppalanchi, R, et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol 2009;7(4):481–6.Google Scholar

Patnaik, MM, Kamath, PS, Simonetto, DA. Hepatic manifestations of telomere biology disorders. J Hepatol 2018;69(3):736–43.Google Scholar

Mangaonkar, AA, Patnaik, MM. Short telomere syndromes in clinical practice: bridging bench and bedside. Mayo Clin Proc 2018;93(7):904–16.Google Scholar

Bristowe, C. Cystic disease of the liver associated with a similar disease of the kidneys. Trans Pathol Soc Lond 1856;7:229–34.Google Scholar

Jorgensen, MJ. The ductal plate malformation. Acta Pathol Microbiol Scand Suppl 1977(257):1–87.Google Scholar

Desmet, VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation.” Hepatology 1992;16(4):1069–83.Google Scholar

Rogers, TN, Woodley, H, Ramsden, W, Wyatt, JI, Stringer, MD. Solitary liver cysts in children: not always so simple. J Pediatr Surg 2007;42(2):333–9.Google Scholar

Kerr, DN, Harrison, CV, Sherlock, S, Walker, RM. Congenital hepatic fibrosis. Q J Med 1961;30:91–117.Google Scholar

Ward, CJ, Hogan, MC, Rossetti, S, Walker, D, Sneddon, T, Wang, X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30(3):259–69.Google Scholar

Bergmann, C, Senderek, J, Windelen, E, Kupper, F, Middeldorf, I, Schneider, F, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int 2005;67(3):829–48.Google Scholar

Rossetti, S, Torra, R, Coto, E, Consugar, M, Kubly, V, Malaga, S, et al. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 2003;64(2):391–403.Google Scholar

O’Brien, K, Font-Montgomery, E, Lukose, L, Bryant, J, Piwnica-Worms, K, Edwards, H, et al. Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease. J Pediatr Gastroenterol Nutr 2012;54(1):83–9.Google Scholar

Gunay-Aygun, M, Gahl, WA, Heller, T. (1993). Congenital hepatic fibrosis overview. In: Adam, MP, Ardinger, HH, Pagon, RA, Wallace, SE, Bean, LJH, Stephens, K, et al., (Eds.), GeneReviews((R)). Seattle, WA: University of Washington.Google Scholar

Srinath, A, Shneider, BL. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr 2012;54(5):580–7.Google Scholar

Gunay-Aygun, M, Font-Montgomery, E, Lukose, L, Tuchman Gerstein, M, Piwnica-Worms, K, Choyke, P, et al. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology 2013;144(1):112–21 e2.Google Scholar

Summerfield, JA, Nagafuchi, Y, Sherlock, S, Cadafalch, J, Scheuer, PJ. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol 1986;2(2):141–56.Google Scholar

Guay-Woodford, LM, Bissler, JJ, Braun, MC, Bockenhauer, D, Cadnapaphornchai, MA, Dell, KM, et al. Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J Pediatr 2014;165(3):611–17.Google Scholar

Akhan, O, Karaosmanoglu, AD, Ergen, B. Imaging findings in congenital hepatic fibrosis. Eur J Radiol 2007;61(1):18–24.Google Scholar

Kummer, S, Sagir, A, Pandey, S, Feldkotter, M, Habbig, S, Korber, F, et al. Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection. Pediatr Nephrol 2011;26(5):725–31.Google Scholar

Wicher, D, Jankowska, I, Lipinski, P, Szymanska-Rozek, P, Kmiotek, J, Janczyk, W, et al. Transient elastography for detection of liver fibrosis in children with autosomal recessive polycystic kidney disease. Front Pediatr 2018;6:422.Google Scholar

Hartung, EA, Wen, J, Poznick, L, Furth, SL, Darge, K. Ultrasound elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease. J Pediatr 2019;209:107–15.Google Scholar

Munoz-Garrido, P, Marin, JJ, Perugorria, MJ, Urribarri, AD, Erice, O, Saez, E, et al. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease. J Hepatol 2015;63(4):952–61.Google Scholar

Shneider, BL, de Ville de Goyet, J, Leung, DH, Srivastava, A, Ling, SC, Duche, M, et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology 2016;63(4):1368–80.Google Scholar

Shneider, BL, Magid, MS. Liver disease in autosomal recessive polycystic kidney disease. Pediatric Transplantation 2005;9(5):634–9.Google Scholar

Guay-Woodford, LM, Desmond, RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 2003;111(5 Pt 1):1072–80.Google Scholar

Garcia-Tsao, G, Sanyal, AJ, Grace, ND, Carey, W. Practice Guidelines Committee of the American Association for the Study of Liver Disease, Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46(3):922–38.Google Scholar

Kinugasa, H, Nouso, K, Kobayashi, Y, Yasunaka, T, Onishi, H, Nakamura, S, et al. Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease. Hepatol Res 2011;41(3):277–81.Google Scholar

Onuchic, LF, Furu, L, Nagasawa, Y, Hou, X, Eggermann, T, Ren, Z, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 2002;70(5):1305–17.Google Scholar

Lu, H, Galeano, MCR, Ott, E, Kaeslin, G, Kausalya, PJ, Kramer, C, et al. Mutations in DZIP1 L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease. Nat Genet 2017;49(7):1025–34.Google Scholar

Caroli, J, Couinaud, C, Soupault, R, Porcher, P, Eteve, J. A new disease, undoubtedly congenital, of the bile ducts: unilobar cystic dilation of the hepatic ducts. Sem Hop 1958;34(8/2):496–502.Google Scholar

Jordon, D, Harpaz, N, Thung, SN. Caroli’s disease and adult polycystic kidney disease: a rarely recognized association. Liver 1989;9(1):30–5.Google Scholar

Rawat, D, Kelly, DA, Milford, DV, Sharif, K, Lloyd, C, McKiernan, PJ. Phenotypic variation and long-term outcome in children with congenital hepatic fibrosis. J Pediatr Gastroenterol Nutr 2013;57(2):161–6.Google Scholar

Ramond, MJ, Huguet, C, Danan, G, Rueff, B, Benhamou, JP. Partial hepatectomy in the treatment of Caroli’s disease. Report of a case and review of the literature. Dig Dis Sci 1984;29(4):367–70.Google Scholar

Lendoire, JC, Raffin, G, Grondona, J, Bracco, R, Russi, R, Ardiles, V, et al. Caroli’s disease: report of surgical options and long-term outcome of patients treated in Argentina. Multicenter study. J Gastrointest Surg 2011;15(10):1814–19.Google Scholar

Kim, RD, Book, L, Haafiz, A, Schwartz, JJ, Sorensen, JB, Gonzalez-Peralta, RP. Liver transplantation in a 7-month-old girl with Caroli’s disease. J Pediatr Surg 2011;46(8):1638–41.Google Scholar

Millwala, F, Segev, DL, Thuluvath, PJ. Caroli’s disease and outcomes after liver transplantation. Liver Transpl 2008;14(1):11–17.Google Scholar

Harris, PC, Torres, VE. Polycystic kidney disease. Annu Rev Med 2009;60:321–37.Google Scholar

Cornec-Le Gall, E, Torres, VE, Harris, PC. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol 2018;29(1):13–23.Google Scholar

Porath, B, Gainullin, VG, Cornec-Le Gall, E, Dillinger, EK, Heyer, CM, Hopp, K, et al. Mutations in GANAB, encoding the glucosidase II alpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 2016;98(6):1193–207.Google Scholar

Dell, KM. The spectrum of polycystic kidney disease in children. Adv Chronic Kidney Dis 2011;18(5):339–47.Google Scholar

Gascue, C, Katsanis, N, Badano, JL. Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms. Pediatr Nephrol 2011;26(8):1181–95.Google Scholar

Wilson, PD. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol 2004;36(10):1868–73.Google Scholar

Lee-Law, PY, van de Laarschot, LFM, Banales, JM, Drenth, JPH. Genetics of polycystic liver diseases. Curr Opin Gastroenterol 2019;35(2):65–72.Google Scholar

Gimpel, C, Bergmann, C, Bockenhauer, D, Breysem, L, Cadnapaphornchai, MA, Cetiner, M, et al. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol 2019;15(11):713–26.Google Scholar

Bae, KT, Zhu, F, Chapman, AB, Torres, VE, Grantham, JJ, Guay-Woodford, LM, et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 2006;1(1):64–9.Google Scholar

Gunay-Aygun, M. Liver and kidney disease in ciliopathies. Am J Med Genet C Semin Med Genet 2009;151 C(4):296–306.Google Scholar

Torres, VE, Harris, PC, Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 2007;369(9569):1287–301.Google Scholar

Janssens, P, Weydert, C, De Rechter, S, Wissing, KM, Liebau, MC, Mekahli, D. Expanding the role of vasopressin antagonism in polycystic kidney diseases: from adults to children? Pediatr Nephrol 2018;33(3):395–408.Google Scholar

Chebib, FT, Perrone, RD, Chapman, AB, Dahl, NK, Harris, PC, Mrug, M, et al. A practical guide for treatment of rapidly progressive ADPKD with tolvaptan. J Am Soc Nephrol 2018;29(10):2458–70.Google Scholar

Desmet, VJ. Ludwig symposium on biliary disorders–part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998;73(1):80–9.Google Scholar

Burns, CD, Kuhns, JG, Wieman, TJ. Cholangiocarcinoma in association with multiple biliary microhamartomas. Arch Pathol Lab Med 1990;114(12):1287–9.Google Scholar

Xu, AM, Xian, ZH, Zhang, SH, Chen, XF. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2009;21(5):580–4.Google Scholar

Nagano, Y, Matsuo, K, Gorai, K, Sugimori, K, Kunisaki, C, Ike, H, et al. Bile duct hamartomas (von Mayenburg complexes) mimicking liver metastases from bile duct cancer: MRC findings. World J Gastroenterol 2006;12(8):1321–3.Google Scholar

Temmerman, F, Missiaen, L, Bammens, B, Laleman, W, Cassiman, D, Verslype, C, et al. Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther 2011;34(7):702–13.Google Scholar

van Keimpema, L, Nevens, F, Vanslembrouck, R, van Oijen, MG, Hoffmann, AL, Dekker, HM, et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009;137(5):1661–8 e1–2.Google Scholar

Gevers, TJ, Drenth, JP. Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol 2013;10(2):101–8.Google Scholar

Kabbej, M, Sauvanet, A, Chauveau, D, Farges, O, Belghiti, J. Laparoscopic fenestration in polycystic liver disease. Br J Surg 1996;83(12):1697–701.Google Scholar

Hoevenaren, IA, Wester, R, Schrier, RW, McFann, K, Doctor, RB, Drenth, JP, et al. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int 2008;28(2):264–70.Google Scholar

Drenth, JP, Chrispijn, M, Nagorney, DM, Kamath, PS, Torres, VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010;52(6):2223–30.Google Scholar

Doshi, SD, Bittermann, T, Schiano, TD, Goldberg, DS. Waitlisted candidates with polycystic liver disease are more likely to be transplanted than those with chronic liver failure. Transplantation 2017;101(8):1838–44.Google Scholar

Waanders, E, te Morsche, RH, de Man, RA, Jansen, JB, Drenth, JP. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum Mutat 2006;27(8):830.Google Scholar

Drenth, JP, Tahvanainen, E, te Morsche, RH, Tahvanainen, P, Kaariainen, H, Hockerstedt, K, et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology 2004;39(4):924–31.Google Scholar

Jaeken, J, Matthijs, G, Saudubray, JM, Dionisi-Vici, C, Bertini, E, de Lonlay, P, et al. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 1998;62(6):1535–9.Google Scholar

Janssen, MJ, Waanders, E, Te Morsche, RH, Xing, R, Dijkman, HB, Woudenberg, J, et al. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease. Gastroenterology 2011;141(6):2056–63 e2.Google Scholar

Lu, W, Fan, X, Basora, N, Babakhanlou, H, Law, T, Rifai, N, et al. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 1999;21(2):160–1.Google Scholar

Wills, ES, Roepman, R, Drenth, JP. Polycystic liver disease: ductal plate malformation and the primary cilium. Trends Mol Med 2014;20(5):261–70.Google Scholar

Carone, FA, Nakamura, S, Schumacher, BS, Punyarit, P, Bauer, KD. Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro. Kidney Int 1989;35(6):1351–7.Google Scholar

Calvet, JP. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation? Kidney Int 1993;43(1):101–8.Google Scholar

Nauta, J, Sweeney, WE, Rutledge, JC, Avner, ED. Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr Res 1995;37(6):755–63.Google Scholar

Santos-Laso, A, Izquierdo-Sanchez, L, Lee-Law, PY, Perugorria, MJ, Marzioni, M, Marin, JJ, et al. New advances in polycystic liver diseases. Semin Liver Dis 2017;37(1):45–55.Google Scholar

Masyuk, AI, Masyuk, TV, Splinter, PL, Huang, BQ, Stroope, AJ, LaRusso, NF. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology 2006;131(3):911–20.Google Scholar

Nauli, SM, Alenghat, FJ, Luo, Y, Williams, E, Vassilev, P, Li, X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003;33(2):129–37.Google Scholar

Chebib, FT, Sussman, CR, Wang, X, Harris, PC, Torres, VE. Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat Rev Nephrol 2015;11(8):451–64.Google Scholar

Graf, A, Meng, F, Hargrove, L, Kennedy, L, Han, Y, Francis, T, et al. Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling. Am J Physiol Gastrointest Liver Physiol 2014;307(8):G813–23.Google Scholar

Banales, JM, Masyuk, TV, Gradilone, SA, Masyuk, AI, Medina, JF, LaRusso, NF. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology 2009;49(1):160–74.Google Scholar

Spirli, C, Okolicsanyi, S, Fiorotto, R, Fabris, L, Cadamuro, M, Lecchi, S, et al. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology 2010;138(1):360–71 e7.Google Scholar

Spirli, C, Okolicsanyi, S, Fiorotto, R, Fabris, L, Cadamuro, M, Lecchi, S, et al. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 2010;51(5):1778–88.Google Scholar

Alvaro, D, Onori, P, Alpini, G, Franchitto, A, Jefferson, DM, Torrice, A, et al. Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol 2008;172(2):321–32.Google Scholar

Masyuk, TV, Masyuk, AI, LaRusso, NF. Therapeutic targets in polycystic liver disease. Curr Drug Targets 2017;18(8):950–7.Google Scholar

Sanzen, T, Harada, K, Yasoshima, M, Kawamura, Y, Ishibashi, M, Nakanuma, Y. Polycystic kidney rat is a novel animal model of Caroli’s disease associated with congenital hepatic fibrosis. Am J Pathol 2001;158(5):1605–12.Google Scholar

Goto, M, Hoxha, N, Osman, R, Wen, J, Wells, RG, Dell, KM. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr 2010;50(6):639–44.Google Scholar

Moyer, JH, Lee-Tischler, MJ, Kwon, HY, Schrick, JJ, Avner, ED, Sweeney, WE, et al. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 1994;264(5163):1329–33.Google Scholar

Guay-Woodford, LM, Green, WJ, Lindsey, JR, Beier, DR. Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum Mol Genet 2000;9(5):769–78.Google Scholar

Raynaud, P, Tate, J, Callens, C, Cordi, S, Vandersmissen, P, Carpentier, R, et al. A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology 2011;53(6):1959–66.Google Scholar

Yoder, BK, Richards, WG, Sommardahl, C, Sweeney, WE, Michaud, EJ, Wilkinson, JE, et al. Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion. Am J Pathol 1997;150(6):2231–41.Google Scholar

Isfort, RJ, Cody, DB, Doersen, CJ, Richards, WG, Yoder, BK, Wilkinson, JE, et al. The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene 1997;15(15):1797–803.Google Scholar

El-Youssef, M, Mu, Y, Huang, L, Stellmach, V, Crawford, SE. Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell. J Pediatr Gastroenterol Nutr 1999;28(4):386–92.Google Scholar

Locatelli, L, Cadamuro, M, Spirli, C, Fiorotto, R, Lecchi, S, Morell, CM, et al. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology 2016;63(3):965–82.Google Scholar

Lee, SO, Masyuk, T, Splinter, P, Banales, JM, Masyuk, A, Stroope, A, et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 2008;118(11):3714–24.Google Scholar

Hand, NJ, Master, ZR, Eauclaire, SF, Weinblatt, DE, Matthews, RP, Friedman, JR. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology 2009;136(3):1081–90.Google Scholar

Lopez-Terrada, D, Finegold, M. (2014). Tumors of the liver. In: Suchy, F, Sokol, RJ, Balistreri, WF, (Eds.), Liver Disease in Children, 4th edn. (pp. 728–59). Cambridge: Cambridge University Press.Google Scholar

Czauderna, P, Haeberle, B, Hiyama, E, et al. The Children’s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 2016;52:92–101.Google Scholar

National Institutes of Health. Surveillance, Epidemiology, and End Results Program (SEER). Available at: https://seer.cancer.gov/csr/1975_2016/ [last accessed June 30, 2020].Google Scholar

Darbari, A, Sabin, KM, Shapiro, CN, Schwarz, KB. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003;38:560–6.Google Scholar

Hubbard, AK, Spector, LG, Fortuna, G, Marcotte, EL, Poynter, JN. Trends in international incidence of pediatric cancers in children under 5 years of age: 1988–2012. JNCI Cancer Spectr 2019;3:pkz007.Google Scholar

Katzenstein, HM, Krailo, MD, Malogolowkin, MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003;97:2006–12.Google Scholar

McLaughlin, CC, Baptiste, MS, Schymura, MJ, Nasca, PC, Zdeb, MS. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006;163:818–28.Google Scholar

Spector, LG, Puumala, SE, Carozza, SE, et al. Cancer risk among children with very low birth weights. Pediatrics 2009;124:96–104.Google Scholar

Janitz, AE, Ramachandran, G, Tomlinson, GE, et al. Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group. J Expo Sci Environ Epidemiol 2017;27:359–64.Google Scholar

Duffy, KA, Cohen, JL, Elci, OU, Kalish, JM. Development of the serum alpha-fetoprotein reference range in patients with Beckwith-Wiedemann spectrum. J Pediatr 2019. doi: 10.1016/j.jpeds.2019.1005.1051Google Scholar

Li, M, Shuman, C, Fei, YL, et al. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 2001;102:161–8.Google Scholar

Aretz, S, Koch, A, Uhlhaas, S, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006;47:811–18.Google Scholar

Roy, A, Finegold, MJ. Hepatic neoplasia and metabolic diseases in children. Clin Liver Dis 2010;14:731–46.Google Scholar

Evason, K, Bove, KE, Finegold, MJ, et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies. Am J Surg Pathol 2011;35:687–96.Google Scholar

Scheimann, AO, Strautnieks, SS, Knisely, AS, et al. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr 2007;150:556–9.Google Scholar

Vilarinho, S, Erson-Omay, EZ, Harmanci, AS, et al. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations. J Hepatol 2014;61:1178–83.Google Scholar

Zen, Y, Vara, R, Portmann, B, Hadzic, N. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM. Histopathology 2014;64:671–82.Google Scholar

Newsome, JR, Venkatramani, R, Heczey, A, et al. Cholangiocarcinoma among children and adolescents: a review of the literature and surveillance, epidemiology, and end results program database analysis. J Pediatr Gastroenterol Nutr 2018;66:e12–e18.Google Scholar

Hadzic, N, Finegold, MJ. Liver neoplasia in children. Clin Liver Dis 2011;15:443–62,vii–x.Google Scholar

Richter, A, Grabhorn, E, Schulz, A, et al. Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transplant 2005;9:805–8.Google Scholar

Kadakia, N, Lobritto, SJ, Ovchinsky, N, et al. A challenging case of hepatoblastoma concomitant with autosomal recessive polycystic kidney disease and Caroli syndrome-review of the literature. Front Pediatr 2017;5:114.Google Scholar

Johansen, L, Haller, W, Thyagarajan, M, Kelly, D, McKiernan, P. Hepatic lesions associated with McCune Albright syndrome. J Pediatr Gastroenterol Nutr 2019;68:e54–e57.Google Scholar

Osada, A, Araki, E, Yamashita, Y, Ishii, T. Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma. Clin Pediatr Endocrinol 2019;28:9–14.Google Scholar

Lemoine, C, Nilsen, A, Brandt, K, et al. Liver histopathology in patients with hepatic masses and the Abernethy malformation. J Pediatr Surg 2019;54:266–71.Google Scholar

McCarville, MB, Kao, SC. Imaging recommendations for malignant liver neoplasms in children. Pediatr Blood Cancer 2006;46:2–7.Google Scholar

Liu, AP, Wong, KN, See, QW, Chan, GC, Chiang, AK. 11 C-Acetate positron emission tomography for detection of occult metastatic recurrence in hepatoblastoma. J Pediatr Hematol Oncol 2016;38:317–20.Google Scholar

Shi, Y, Commander, SJ, Masand, PM, et al. Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg 2017;52:956–61.Google Scholar

Boman, F, Bossard, C, Fabre, M, et al. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg 2004;14:63–6.Google Scholar

Meyers, RL, Maibach, R, Hiyama, E, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 2017;18:122–31.Google Scholar

Rudzinski, E, Ranganathan, S, Hicks, MJ, Kim, GE. Protocol for the examination of resection specimens from patients with hepatoblastoma. Available at: https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates [last accessed June 30, 2020].Google Scholar

Aronson, DC, Schnater, JM, Staalman, CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245–52.Google Scholar

Meyers, R, Trobaugh-Lotrario, AD, Malogolowkin, MH, Katzenstein, HM, Lopez-Terrada, DH, Finegold, MJ. (2016). Pediatric liver tumors. In: PA Pizzo, (Ed.), Principles and Practice of Pediatric Oncology, 7th edn. (p. 726–52). Philadelphia: Wolters Kluwer.Google Scholar

Wang, LL, Filippi, RZ, Zurakowski, D, et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010;34:287–99.Google Scholar

Biegel, JA, Tan, L, Zhang, F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461–7.Google Scholar

Trobaugh-Lotrario, AD, Finegold, MJ, Feusner, JH. Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy. Pediatr Blood Cancer 2011;57:423–8.Google Scholar

Trobaugh-Lotrario, AD, Tomlinson, GE, Finegold, MJ, Gore, L, Feusner, JH. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009;52:328–34.Google Scholar

Kiss, A, Szepesi, A, Lotz, G, et al. Expression of transforming growth factor-alpha in hepatoblastoma. Cancer 1998;83:690–7.Google Scholar

Lopez-Terrada, D, Alaggio, R, de Davila, MT, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014;27:472–91.Google Scholar

Zhou, S, Gomulia, E, Mascarenhas, L, Wang, L. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable? Hum Pathol 2015;46:620–4.Google Scholar

Prokurat, A, Kluge, P, Kosciesza, A, et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 2002;39:510–18.Google Scholar

Benedict, M, Zhang, X. Calcifying nested stromal-epithelial tumor of the liver: an update and literature review. Arch Pathol Lab Med 2019;143:264–8.Google Scholar

Assmann, G, Kappler, R, Zeindl-Eberhart, E, et al. beta-Catenin mutations in 2 nested stromal epithelial tumors of the liver–a neoplasia with defective mesenchymal-epithelial transition. Hum Pathol 2012;43:1815–27.Google Scholar

Mo, JQ, Dimashkieh, HH, Bove, KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004;35:200–9.Google Scholar

Iacobas, I, Phung, TL, Adams, DM, et al. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 2018;203:294–300, e292.Google Scholar

Adler, B, Naheedy, J, Yeager, N, Nicol, K, Klamar, J. Multifocal epithelioid hemangioendothelioma in a 16-year-old boy. Pediatr Radiol 2005;35:1014–18.Google Scholar

Antonescu, CR, Le Loarer, F, Mosquera, JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013;52:775–84.Google Scholar

Doyle, LA, Fletcher, CD, Hornick, JL. Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol 2016;40:94–102.Google Scholar

Grassia, KL, Peterman, CM, Iacobas, I, et al. Clinical case series of pediatric hepatic angiosarcoma. Pediatr Blood Cancer 2017;64:e26627.Google Scholar

Shehata, BM, Gupta, NA, Katzenstein, HM, et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol 2011;14:111–16.Google Scholar

Keller, RB, Demellawy, DE, Quaglia, A, Finegold, M, Kapur, RP. Methylation status of the chromosome arm 19q MicroRNA cluster in sporadic and androgenetic-biparental mosaicism-associated hepatic mesenchymal hamartoma. Pediatr Dev Pathol 2015;18:218–27.Google Scholar

Yan, Z, Grenert, JP, Joseph, NM, et al. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. Histopathology 2018;73:101–8.Google Scholar